Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

The New EU (European Union) Animal Health Legislation for Veterinary Medicinal Products Training Course

The programme will offer a comprehensive introduction to the new EU Regulation (2019/6) and will address the changes and implications to the industry including marketing authorisations, submissions and dossiers.

3-4 Nov 2022

Book now

Details

Course overview

The new EU Regulation (2019/6) on Veterinary Medicinal Products will be applicable for all EU countries from 28 January 2022 and will have massive implications for all animal health companies operating in, or wanting to operate in the EU. This seminar will provide essential insight into these revolutionary changes and enable participants to plan their regulatory strategies going forward.

The programme will offer a comprehensive introduction to the legislative changes and will address the new issues, marketing authorisation (MA) submissions and dossiers. Data protection and routes to market will be discussed, as will post-marketing measures and variations. The implications for supply and use, off-label use and inspection controls will also be covered.

This is a must-attend seminar for all animal health professionals.

Benefits of attending:

  • Be prepared for the revolutionary changes to the EU legislation
  • Gain essential guidance on the implications of the changes
  • Understand how this will affect you and your company
  • Hear the implications on variations
  • Be aware of the opportunities the changes will create
  • Comply with data protection and routes to market
  • Understand the post-market measures
  • Plan for the impact on supply and use

Who should attend?

This seminar will be beneficial to all those working in the animal health industry including:

  • Regulatory affairs managers
  • R&D associates
  • Manufacturing professionals
  • Sales and marketing managers
  • Directors and CEOs
  • Personnel who are new to the animal health industry and all those needing an overview of the new legislation

Presenters

Mel Munro (More...)

Dr Mel Munro has worked as a consultant in veterinary medicinal product development and registration for over 20 years. She provides regulatory advice on all areas of biologicals product development taking client projects from proof of concept through to Marketing Authorisation (MA). On a day-to-day basis, she advises on regulatory strategy, performs technical due diligence and gap analyses and prepares strategic development plans and expert reports. She is also experienced in negotiation with the regulators and preparing regulatory documentation. Over her career she has been involved in numerous biologicals projects ranging from more ‘conventional’ vaccines to novel biologicals such as products of rDNA technology, GMO’s, monoclonal antibodies, DNA vaccines and gene therapy.


Karolina Bate (More...)

Karolina has worked in regulatory affairs for over 15 years. Karolina started her career working for Cyton Biosciences, becoming a Managing Director 8 years ago. Since the acquisition of kAH Ltd (formally Triveritas) in 2020, she manages the multi-disciplinary product development support which both companies provide to the animal health industry. Together with support from two other knoell Animal Health consultancies, one based in Germany the other in the USA, and knoell experts in Shanghai; knoell provides global regulatory services to its clients.

Prior to working for Cyton, Karolina carried out her Pharmacology degree and Immunology PhD at the University of Cardiff, Wales. Karolina spent a few years working in University research laboratories and teaching before moving into the field of regulatory affairs.

Book now

Book now

NEW higher discounts for booking multiple places - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate
  • 40% off the 3rd delegate
  • 50% off the 4th delegate
3-4 Nov 2022
Live webinar
09:00-17:30
UK (London)
3-4 Nov 2022
Live webinar
09:00-17:30
UK (London)
GBP 1,199 999
EUR 1,719 1,439
USD 1,942 1,630
Until 29 Sep*
Enrol now
to attend
Live webinar

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code. As such, discounts for the 2nd/3rd/4th attendees are based on the full price of the course. Please contact us for pricing if you wish to send more than 4 delegates.

Continuing professional development

This course qualifies for 12 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

Previous customers include...

  • Bela-Pharm GmbH & Co. KG
  • biovac
  • Boehrigner Ingelheim VRC GmbH & Co. KG
  • BOEHRINGER INGELHEIM - ANIMAL HEALTH FRANCE
  • Boehringer Ingelheim Animal Health Nordics A/S
  • Boehringer Ingelheim Animal Health UK Ltd.
  • Boehringer Inghelheim Animal Health Netherlands B.V.
  • Chef du Monde
  • Cross Vetpharm Group UK Ltd
  • DADA Consultancy BV
  • Elanco Animal Health
  • Elanco Deutschland GmbH
  • European Medicines Agency
  • FATRO S.p.A.
  • Hifarmax, Produtos e Serviços Veterinários, Lda.
  • Norbrook Laboratories Ltd
  • Nutreco Nederland BV
  • Parexel International Ltd.
  • Pharmacosmos
  • Pharmacosmos A/S
  • Prionics Lelystad B.V.
  • Regivet BV
  • Research and Markets
  • Univet Ltd
  • Vana GmbH
  • Vetcare Ltd
  • Vetcare Oy
  • Vetoquinol Biowet
  • VETOQUINOL S.A.
  • Zoetis Deutschland GmbH

It was very interesting, thorough and informative. I enjoyed following the course and listening to the presenter.

Rachael Benjamin, Regulatory Affairs Officer, Beaphar B.V., Nov 21

I wanted to get more familiar with the new legislation, to understand a bit more about its background. This course helped me a lot in understanding more of the thoughts behind the various articles.

Charlotte Jacobs, Regulatory Affairs Officer, Beaphar B.V., Nov 21

I wanted to hear about the new animal health legislation - which Julian Braidwood succeeded in doing.

Marianne Valentin Hansen, Drug Safety Specialist, Pharmacosmos, Nov 21

Julian was speaking in clear language and in a nice tempo (not to quick, not to slow). He acted immediately if a participant wanted to ask a question...Very good, very comprehensive.

Tonny van Dijk, Sr. Regulatory Affairs Specialist, Prionics Lelystad B.V., Nov 21

was really good for me as I am just starting my activities on VMP and I need to understand more new regulation

Karine Tanan, Principal Scientist, Scientific and Regulatory Affairs, Cargill R and D Centre Europe, Nov 21

I really thought Julian was excellent, very engaging, and really informed

Siobhan Crowe, Pharmacist, Univet Ltd, Nov 21

Very good!

Ruud Huibers, Advisor Regulatory Affairs Pharma EU, Elanco Deutschland GmbH, May 21

Content = good however some of the points were of little relevance to me.
Presentation = excellent. Very clear slides and the speed of delivery was perfect.
Speaker = excellent. Very knowledgeable and happy to discuss topics in depth if required

Rodney Cartmill, Head of Regulatory Affairs - New Products, Norbrook Laboratories Ltd, Nov 20

An interesting, informative and interactive two-day course which provided a clear overview and explanation of the most important changes that we can expect as a result of the 2019/6 Legislation. It is not easy to keep the audience interested while explaining a new law but Julian managed to do this excellently.

Kitty Ruigrok, DVM, Regivet BV, Dec 19

The main themes of the new Regulation were presented in a precise but detailed manner and this, coupled with the extensive knowledge and sympathetic manner of the speaker, make the course something special.

Heike Luckow, Regulatory Affairs, Bela-Pharm GmbH & Co. KG, Dec 19

Julian was a fantastic presenter, with excellent examples of real-life scenarios making a potentially dry course thoroughly enjoyable.

Jennifer Hynes, Quality Manager, Benchmark Vaccines Limited, Mar 19